Skip to main content
Log in

Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland)

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Objectives: To compare the risk of cancer between BRCA1 or BRCA2 mutation-positive and -negative families.

Methods: We assessed standardized incidence ratios (SIR) in 107 Finnish breast cancer families (12 BRCA1, 11 BRCA2, 84 non-BRCA1/2) with confirmed genealogy. The observed numbers of cancer cases were compared to the expected ones; both numbers were based on the population-based Finnish Cancer Registry.

Results: Risk of ovarian cancer for first-degree relatives was high in BRCA1 (SIR 29, 95% confidence interval 9.4–68) and in BRCA2 families (SIR 18, 8.3–35), but not increased for non-BRCA1/2 families (SIR 1.0, 0.2–2.9). The SIR for subsequent ovarian cancer among breast cancer patients was 61 (20–142), 38 (11–98), and 0 (0–4.2), respectively. The risk of subsequent new breast cancer among breast cancer patients was equally high in BRCA1 families (SIR 11, 3.6–26) and in BRCA2 families (SIR 10, 3.3–24) and somewhat lower in mutation-negative families (SIR 3.7, 2.1–6.1). The risk of breast cancer among relatives was markedly increased in all three groups. The only elevated SIR, besides breast and ovarian, was that for prostate cancer in BRCA2 families (SIR 4.9, 1.8–11).

Conclusions: The excess risk of breast cancer in non-BRCA1/2 families suggests the existence of another predisposition gene which seems not to be linked with increased risk of ovarian cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Colditz GA, Willett WC, Hunter DJ, et al. (1993) Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study. JAMA 270: 338–343.

    Google Scholar 

  2. Tulinius H, Sigvaldason H, Olafsdottir GH, et al. (1992) Epidemiology of breast cancer in families in Iceland. J Med Genet 29: 158–164.

    Google Scholar 

  3. Houlston RS, McCarter E, Parbhoo S, et al. (1992) Family history and risk of breast cancer. J Med Genet 29: 154–157.

    Google Scholar 

  4. Schildkraut J, Risch N, Thompson W (1989) Evaluating genetic association among ovarian, breast and endometrial cancer, evidence for a breast/ovarian cancer relationship. Am J Hum Genet 45: 521–529.

    Google Scholar 

  5. Miki Y, Swensen J, Shattuck-Eidens D, et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71.

    Google Scholar 

  6. Wooster R, Bignell G, Lancaster J, et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789–792.

    Google Scholar 

  7. Ford D, Easton DF, Bishop DT, et al. (1994) Risks of cancer in BRCA1-mutation carriers. Lancet 343: 692–695.

    Google Scholar 

  8. Easton D, Ford D, Bishop T, et al. (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56: 265–271.

    Google Scholar 

  9. Ford D, Easton DF, Stratton M, et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62: 676–689.

    Google Scholar 

  10. Easton D, Consortium BCL (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91: 1310–1316.

    Google Scholar 

  11. Struewing JP, Hartge PW, Wacholder S, et al. (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336: 1401–1408.

    Google Scholar 

  12. Warner E, Foulkes W, Goodwin P, et al. (1999) Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91: 1241–1247.

    Google Scholar 

  13. Thorlacius S, Struewing JP, Hartge P, et al. (1998) Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 352: 1337–1339.

    Google Scholar 

  14. Peto J, Collins N, Barfoot R, et al. (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91: 943–949.

    Google Scholar 

  15. Hopper J, Southey MC, Dite GS, et al. (1999) Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Cancer Epidemiol 8: 741–747.

    Google Scholar 

  16. Johansson O, Loman N, Möller T, Kristoffersson U, Borg Å, Olsson H (1999) Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers. Eur J Cancer 35: 1248–1257.

    Google Scholar 

  17. Vehmanen P, Friedman LS, Eerola H, et al. (1997) Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families, evidence for additional susceptibility genes. Hum Mol Genet 6: 2309–2315.

    Google Scholar 

  18. Eerola H, Blomqvist C, Pukkala E, Pyrhönen S, Nevanlinna H (2000) Familial breast cancer in Southern Finland: How prevalent are breast cancer families and can we trust the family history reported by the patients? Eur J Cancer 36: 1143–1148.

    Google Scholar 

  19. Vehmanen P, Friedman LS, Eerola H, et al. (1997) A low proportion of BRCA2 mutations in Finnish breast cancer families. Am J Hum genet 60: 1050–1058.

    Google Scholar 

  20. Vahteristo P, Eerola H, Tamminen A, Blomqvist C, Nevanlinna H (2001) A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families. Br J Cancer 84: 704–708.

    Google Scholar 

  21. Sarantaus L, Huusko P, Eerola H, et al. (2000) Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland. Eur J Hum Genet 8: 757–763.

    Google Scholar 

  22. Huusko P, Pääkkönen K, Launonen V, et al. (1998) Evidence for founder mutations in Finnish BRCA1 and BRCA2 families. Am J Hum Genet 62: 1544–1548.

    Google Scholar 

  23. Syrjäkoski K, Vahteristo P, Eerola H, et al. (2000) Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. J Natl Cancer Inst 92: 1529–1531.

    Google Scholar 

  24. Teppo L, Pukkala E, Lehtonen M (1994) Data quality and quality control of a population-based cancer registry. Acta Oncol 33: 365–369.

    Google Scholar 

  25. SPSS for Windows, Rel 8.0.1.1998. Chicago: SPSS.

  26. Statview for PowerPC, Rel 4.5.1, 1995. Berkeley, CA: Abacus Concepts.

  27. Claus EB, Schildkraut JM, Thompson WD, et al. (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77: 2318–2324.

    Google Scholar 

  28. Gayther SA, Mangion J, Russel P, et al. (1997) Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 15: 103–105.

    Google Scholar 

  29. Teppo L, Pukkala E, Saxen E (1985) Multiple cancer — an epidemiologic exercise in Finland. J Natl Cancer Inst 75: 207–217.

    Google Scholar 

  30. Kainu T, Juo SH, Desper R, et al. (2000) Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci 97: 9693–9708.

    Google Scholar 

  31. Easton DF, Steele L, Fields P, et al. (1997) Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 61: 120–128.

    Google Scholar 

  32. Love RR, Evans AM, Josten DM (1985) The accuracy of patient reports of a family history of cancer. J Chron Dis 38: 289–293.

    Google Scholar 

  33. Kerber RA, Slattery ML (1997) Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 146: 244–248.

    Google Scholar 

  34. Gladstone A, Adatto P, Cunningham J, et al. (1998) Family history of cancer in patients with glioma, a validation study of accuracy. J Natl Cancer Inst 90: 543–544.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eerola, H., Pukkala, E., Pyrhönen, S. et al. Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland). Cancer Causes Control 12, 739–746 (2001). https://doi.org/10.1023/A:1011272919982

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011272919982

Navigation